Light/dark cycle manipulation influences mice behaviour in the elevated plus maze

Behavioural Brain Research

Volumn 166, Issue 1, 2006, Pages 140-149

  Clénet, Florence ^a   Bouyon, Eric ^a   Hascoët, Martine ^a   Bourin, Michel ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Anxiety; Benzodiazepine; Elevated plus maze (EPM); GABA; Light; Serotonin

Indexed keywords

DIAZEPAM; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A ANTAGONIST;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ILLUMINATION; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DARKNESS; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; LIGHT; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; PIPERAZINES; PYRIDINES; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 27944449340     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2005.07.018     Document Type: Article

References (70)

1. N. Andrews, and S. File Handling of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety Eur J Pharmacol 235 1991 109 112
2. E.B. Arushanian, and E.V. Beier The contrary effect of destruction of the dorsal hippocampus and of the suprachiasmatic nucleus of the hypothalamus on the rhythmic organization of behaviour and on anxiety in rats Zh Vyssh Nerv Deiat Im I P Pavlova 49 1999 264 270
3. 1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY 100135, but not WAY 100635 has partial agonist properties Eur J Pharmacol 304 1996 15 21
4. D.M. Berson, F.A. Dunn, and M. Takao Phototransduction by retinal ganglion celles that set the circadian clock Science 295 2002 1070 1073
5. D.M. Berson Strange vision: ganglion cells as circadian photoreceptors Trends Neurosci 26 2003 314 320
6. L.J. Bertoglio, and A.P. Carobrez Behavioral profile of rats submitted to session1-session 2 in the elevated plus maze during diurnal/noctural phases and under different illumination conditions Behav Brain Res 132 2002 135 143
7. 1A receptor antagonists (+)WAY 100135 and WAY 100635 Neuropharmacology 34 1995 805 811
8. 1A receptor ligands in the mouse Br J Pharmacol 111 1994 151P
9. J.R. Boissier, P. Simon, and C. Aron A new method for rapid screening of minor tranquillizers in mice Eur J Pharmacol 4 1968 145 151
10. M. Bourin, M. Hascoët, B. Mansouri, M.C. Colombel, and J. Bradwejn Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models J Psychiatr Neurosc 17 1992 72 77
11. F.R.A. Cagampang, S. Yamazaki, Y. Otori, and S.-I.T. Inouye Serotonin in the raphe nuclei: regulation by light and an endogenous pacemaker Neuroreport 4 1993 49 52
12. 1A.receptor antagonist, has anxiolytic-like profile in the murine elevated plus-maze Psychopharmacology 129 1997 365 371
13. 1A Pharmacol Biochem Behav 58 1997 583 591
14. 1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190 Pharmacol Biochem Behav 58 1997 593 603
15. 1A receptor ligands, LY293284, LY315712 and LY 297996, on plus-maze anxiety in mice Psychopharmacology 139 1998 185 194
16. G. Childs, and P.H. Redfern A circadian rhythm in passive avoidance behaviour: the effect of phase shift and the benzodiazepines Neuropharmacology 20 1981 1365 1366
17. F. Clénet, M. Hascoët, G. Fillion, H. Galons, and M. Bourin Role of GABA-ergic and serotonergic systems in the anxiolytic mechanism of action of a 5-HT-moduline antagonist in the mouse elevated plus maze Behav Brain Res 158 2005 339 348
18. 1A receptor antagonists Curr Drugs Serotonin 1 1993 99 124
19. J.C. Cole, and R.J. Rodgers An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6028) in the murine elevated plus-maze Behav Pharmacol 4 1993 573 580
20. J.C. Cole, and R.J. Rodgers Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze Pharmacol Biochem Behav 52 1995 473 478
21. 1A antagonist, WAY 100635 J Psychoharmacol 10 1996 A46
22. A. Dalvi, and R.J. Rodgers GABAergic influences on plus-maze behaviour in mice Psychopharmacology 128 1996 380 397
23. A. Dalvi, and R.J. Rodgers Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the desinhibition of open arm avoidance Pharmacol Biochem Behav 62 1999 727 734
24. A. Easton, P. Meerlo, B. Bergmann, and F.W. Turek Clock gene expression outside the SCN can modulate sleep time Sleep 25 2002 A304
25. A. Easton, J. Arbuzova, and F.W. Turek The circadian Clock mutation increases exploratory activity and escape-seeking behaviour Genes Brain Behav 2 2003 11 19
26. J.S. Ferraro, and R.W. Steger Diurnal variations in brain serotonin are driven by the photic cycle and are not circadian in nature Brain Res 512 1990 121 124
27. S.E. File Behavioural detection of anxiolytic action J.M. Elliot D.J. Heal C.A. Marsden Experimental approaches to anxiety and depression 1992 Wiley Chichester 25 44
28. 1A receptor antagonists: utility as research tools and therapeutic agents Trends Pharmacol Sci 14 1993 441 448
29. 1A receptor antagonist Behav Brain Res 73 1996 337 353
30. 1A receptor antagonist, WAY 100635 Eur J Pharmacol 281 1995 81 88
31. G.M. Goodwin, R.J. De Souza, A.R. Green, and D.J. Heal The pharmacology of the behavioural and hypothermic responses of rats to 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH-DPAT) Psychopharmacology 91 1987 506 511
32. F.G. Graeff, F.S. Guimaraes, T.G. De Andrade, and J.F. Deakin Role of 5-HT in stress, anxiety, and depression Pharmacol Biochem Behav 54 1996 129 141
33. C.B. Green, and M. Menaker Clocks on the brain Science 301 2003 319 320
34. G. Griebel 5-Hydroxytryptamine-interacting drugs in animal models of anxiety: more than 30 years of research Pharmacol Ther 65 1995 319 395
35. G. Griebel, J.L. Moreau, F. Jenck, J.R. Martin, and R. Misslin Some critical determinants of the behaviour of rats in the elevated plus-maze Behav Proc 29 1993 37 48
36. 1A receptor antagonist is determined by arousal state J Psychopharmacol 8 1994 A13
37. S.L. Handley, and J.W. McBlane 5-HT drugs in animal models of anxiety Psychopharmacology 112 1993 13 20
38. M. Hastings, and E.S. Maywood Circadian clock in the mammalian brain Bioessays 22 2000 23 31
39. 1A partial agonists, full agonists, and antagonists in the murine elevated plus maze Soc Neurosci Abstr 21 1995 1367
40. S. Hogg A review of the validity and variability of the elevated plus-maze as an animal model of anxiety Pharmacol Biochem Behav 54 1996 21 30
41. J.T. Imhof, Z.M.I. Coelho, M.L. Schimdt, G.S. Morato, and A.P. Carobrez Influence of gender and age on performance of rats in the elevated plus-maze apparatus Behav Brain Res 56 1993 177 180
42. B) receptor ligands in the elevated plus-maze test of anxiety in mice Psychopharmacology 124 1996 355 364
43. N. Jones, and S.M. King Influence of circadian phase and test illumination on pre-clinical models of anxiety Physiol Behav 72 2001 99 106
44. I.P. Lapin Only controls: effects of handling, sham injection, and intraperitoneal injection of saline on behaviour of mice in an elevated plus-maze J Pharmacol Toxicol Methods 34 1995 73 77
45. R.G. Lister The use of a plus-maze to measure anxiety in the mouse Psychopharmacology 92 1987 180 185
46. N. Lopes da Silva, V.M.M. Ferreira, A.P. Carobrez, and G.S. Morato Individual housing from rearing modifies the performance of young rats on the elevated plus-maze apparatus Physiol Behav 60 1996 1391 1396
47. 1A receptors to 8-OH-DPAT in rats Psychopharmacology 123 1996 42 45
48. 1A receptors is endogenous in nature Cell Mol Life Sci 53 1997 224 226
49. R. Maldonado, C. Smadja, C. Mazzucchelli, P. Sassone-Corsi, and C. Mazzucchelli Altered emotional and locomotor responses in mice deficient in the transcription factor CREM Proc Natl Acad Sci USA 96 1999 14094 14099
50. J.H. Meijer Photic entrainment of mammals J.S. Takahashi F.W. Turek R.Y. Moore Circadian clocks 2001 Kluwer New York 183 222
51. 1A autoreceptors: actions in models of antidepressive, anxiolytic and promnesic activity Soc Neurosci Abstr 20 1994 1544
52. R.Y. Moore, and R.K. Leak Suprachiasmatic nucleus J.S. Takahashi F.W. Turek R.Y. Moore Circadian clocks 2001 Kluwer New York 141 179
53. 1A receptor antagonist (S)-UH-301 in rodents and monkeys Brain Res Bull 29 1992 901 904
54. P.C. Moser, and P.H. Redfern Circadian variation in behavioural responses to central 5-HT receptor stimulation in the mouse Psychopharmacology 86 1985 223 227
55. H. Nagayama Chronopharmacology of psychotropic drugs: circadian rhythms in drug effects and its applications to rhythms in the brain Pharmacol Ther 59 1993 31 54
56. 2A receptors to DOI in rats Psychopharmacology 127 1996 113 116
57. 1A receptors in laboratory rats Psychopharmacology 135 1998 279 283
58. 2 ligands on three mouse models of anxiety Behav Brain Res 140 2003 203 214
59. P.T. Ninan, J.O. Cole, and K.A. Yonkers Nonbenzodiazepine anxiolytics A.F. Schatzberg C.B. Nemeroff Texbook of psychopharmacology 2nd ed. 1998 American Psychiatric Press Washington, DC 287 300
60. A. Ramos, Y. Mellerin, P. Mormede, and F. Chaouloff A genetic and multifactorial analysis of anxiety-related behaviours in Lewis and SHR intercrosses Behav Brain Res 96 1998 195 205
61. R. Refinetti Effects of prolonged exposure to darkness on circadian photic responsiveness in the mouse Chronobiol Int 20 2003 417 440
62. J.G. Richards, H. Möhler, and W. Haefely Benzodiazepine binding sites: Receptors or acceptors? Trends Pharmacol Sci 3 1982 233
63. 1A receptor antagonist, LY297996 Behav Pharmacol 9 1998 S78
64. R.J. Rodgers, and J.C. Cole The elevated plus-maze: pharmacology, methodology and ethology S.J. Cooper C.A. Hendrie Ethology and psychopharmacology 1994 Wiley Chichester, UK 9 44
65. 1A receptor antagonists Behav Brain Res 73 1996 153 156
66. P.J. Shiromani, and D. Overstreet Free-running period of circadian rhythms is shorter in rats with a genetically upregulated central cholinergic system Biol Psychiatry 36 1994 622 626
67. L.C. Solberg, S.L. Olson, F.W. Turek, and E. Redei Altered hormone levels and circadian rhythm of activity in the WKY rat, a putative animal model of depression Am J Physiol Regul Interg Comp Physiol 281 2001 R786 R794
68. G. Tunncliff Molecular basis of buspirone's anxiolytic action Pharmacol Toxicol 69 1991 149 156
69. L.K.E. Van Esseveldt, M.N. Lehman, and G.J. Boer The suprachiasmatic nucleus and the circadian time-keeping system revisited Brain Res 33 2000 34 77
70. D.R. Wagner Circadian rhythm sleep disorders Curr Treat Options Neurol 1 1999 299 308